Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor - A population-based case-control study
CONCLUSIONS: Unlike in epithelial ovarian cancer, AGCT development is not clearly associated with parity, and users of postmenopausal HT do not seem to carry an excess risk for AGCT formation.PMID:34598830 | DOI:10.1016/j.ygyno.2021.09.013
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Saara Bryk Sushmita Katuwal Ulla-Maija Haltia Johanna Tapper Juha S Tapanainen Eero Pukkala Source Type: research
More News: Cancer | Cancer & Oncology | Epidemiology | Epithelial Cancer | Estradiol | Finland Health | Granulosa Cell Tumor | Hormonal Therapy | Hormones | Men | Menopause | Ovarian Cancer | Ovaries | Study | Women